159 related articles for article (PubMed ID: 38183356)
21. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
22. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
Techasen A; Namwat N; Loilome W; Bungkanjana P; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
[TBL] [Abstract][Full Text] [Related]
24. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.
Wu Z; Boonmars T; Nagano I; Loilome W; Yongvanit P; Khuntikeo N; Nielsen PS; Paorojkul C; Takahashi Y; Maekawa Y
Tumour Biol; 2014 Mar; 35(3):1985-95. PubMed ID: 24122204
[TBL] [Abstract][Full Text] [Related]
25. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
26. PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway.
Hu MD; Jia LH; Wang ML
Cell Biol Int; 2023 Aug; 47(8):1381-1391. PubMed ID: 37067236
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.
Panawan O; Silsirivanit A; Chang CH; Putthisen S; Boonnate P; Yokota T; Nishisyama-Ikeda Y; Detarya M; Sawanyawisuth K; Kaewkong W; Muisuk K; Luang S; Vaeteewoottacharn K; Kariya R; Yano H; Komohara Y; Ohta K; Okada S; Wongkham S; Araki N
Cancer Sci; 2023 Aug; 114(8):3230-3246. PubMed ID: 37026527
[TBL] [Abstract][Full Text] [Related]
28. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
29. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression.
Dwyer BJ; Jarman EJ; Gogoi-Tiwari J; Ferreira-Gonzalez S; Boulter L; Guest RV; Kendall TJ; Kurian D; Kilpatrick AM; Robson AJ; O'Duibhir E; Man TY; Campana L; Starkey Lewis PJ; Wigmore SJ; Olynyk JK; Ramm GA; Tirnitz-Parker JEE; Forbes SJ
J Hepatol; 2021 Apr; 74(4):860-872. PubMed ID: 33221352
[TBL] [Abstract][Full Text] [Related]
30. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
31. AZGP1 deficiency promotes angiogenesis in prostate cancer.
Wen RM; Qiu Z; Marti GEW; Peterson EE; Marques FJG; Bermudez A; Wei Y; Nolley R; Lam N; Polasko AL; Chiu CL; Zhang D; Cho S; Karageorgos GM; McDonough E; Chadwick C; Ginty F; Jung KJ; Machiraju R; Mallick P; Crowley L; Pollack JR; Zhao H; Pitteri SJ; Brooks JD
J Transl Med; 2024 Apr; 22(1):383. PubMed ID: 38659028
[TBL] [Abstract][Full Text] [Related]
32. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
34. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
Chen MH; Lin KJ; Yang WL; Kao YW; Chen TW; Chao SC; Chang PM; Liu CY; Tzeng CH; Chao Y; Chen MH; Yeh CN; Huang CY
Cancer; 2013 Jan; 119(2):293-303. PubMed ID: 22810956
[TBL] [Abstract][Full Text] [Related]
35. NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1.
Shan J; Jiang W; Chang J; Zhou T; Chen Y; Zhang Y; Wang J; Wang Y; Wang Y; Xu X; Liu S; Shi X; Fan S; Chen R; Li C; Li X
Int J Biol Sci; 2023; 19(5):1336-1351. PubMed ID: 37056930
[TBL] [Abstract][Full Text] [Related]
36. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
[TBL] [Abstract][Full Text] [Related]
37. L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression.
Zhu B; Zheng J; Hong G; Bai T; Qian W; Liu J; Hou X
Chin Med J (Engl); 2022 Dec; 135(24):2956-2967. PubMed ID: 36728287
[TBL] [Abstract][Full Text] [Related]
38. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.
Vaeteewoottacharn K; Kariya R; Matsuda K; Taura M; Wongkham C; Wongkham S; Okada S
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1551-62. PubMed ID: 23877657
[TBL] [Abstract][Full Text] [Related]
39. Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β.
You L; Lin J; Yu Z; Qian Y; Bi Y; Wang F; Zhang L; Zheng C; Zhang J; Li W; Cai Y; Gao Y; Kong X; Sun X
Int J Biol Sci; 2022; 18(15):5698-5712. PubMed ID: 36263164
[No Abstract] [Full Text] [Related]
40. AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway.
Deng L; Bao W; Zhang B; Zhang S; Chen Z; Zhu X; He B; Wu L; Chen X; Deng T; Chen B; Yu Z; Wang Y; Chen G
Cell Death Dis; 2023 Sep; 14(9):590. PubMed ID: 37669935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
